Merck & Co (NY:MRK)

What's going on in today's session: dow jones movers ↗

Today 12:40 EDT

Via Chartmill

Performance

52-Week Range 8.5% below 52-week high

143.56

82.0152W Low 156.9252W High

1 Week 4.5% below 1-week high

143.261W Low 150.361W High

Merck & Co (MRK) traded between $82.01 and $156.92 over the past 52 weeks and last traded at $143.56, 8.5% below its 52-week high. Over the past week it ranged between $143.26 and $150.36.

Past 12 Months

-3.5%

-4.2%

+10.8%

+18.8%

+34.9%

+59.3%

1W -$5.22

1M -$6.30

3M +$14.00

6M +$22.69

YTD +$37.11

1Y +$53.43

MRK was +59.3% over the past year, +18.8% over six months, +34.9% year to date, -3.5% in the last week.

12 Months vs Market

MRK

+59.3%

DIA

+10.0%

SPY

+15.1%

QQQ

+24.2%

IWM

+16.1%

Over the past 12 months MRK returned +59.3% versus DIA (Dow) +10.0%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.2% and IWM (Russell 2000) +16.1%.

Volume & Liquidity 0.30× 3-mo avg

Today 2,994,095 3-mo avg 9.8M

8.5M

9.7M

9.8M

10.1M

YTD

10.7M

11.4M

MRK most recently traded 2,994,095 shares against a 3-month average daily volume of 9.8M.

More News

Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29

October 01, 2026

From Merck & Co., Inc

Stay informed with the top movers within the dow jones index on Wednesday. ↗

September 30, 2026

Via Chartmill

Prediction: Moderna Stock Will Soar 100% by 2030 ↗

September 30, 2026

2 Outstanding Dividend Stocks to Buy and Hold for a Decade ↗

September 30, 2026

Merck's Tulisokibart Met Primary and Key Secondary Endpoints in Phase 2b Study in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Uncover the latest developments among dow jones stocks in today's session. ↗

September 30, 2026

Via Chartmill

3 Healthcare Dividend Stocks Offering More Than Just Income ↗

September 30, 2026

Via MarketBeat

September 30, 2026

SCHD's Top Sector Bet Is Healthcare at 20.7%. I'm Not Sure What's More Surprising: What It Doesn't Hold, or What It Does. ↗

September 30, 2026

Unpacking Q2 Earnings: Merck (NYSE:MRK) In The Context Of Other Branded Pharmaceuticals Stocks

3 Cash-Producing Stocks with Open Questions

September 30, 2026

Via StockStory

Which dow jones stocks are moving on Tuesday? ↗

September 29, 2026

Via Chartmill

September 28, 2026

Via StockStory

Merck Enters into Exclusive Global License Agreement with SciBrunch Therapeutics for SPR2015, an Investigational Oral KRAS G12D (ON) Inhibitor

September 28, 2026

U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)

Friday's session: top gainers and losers in the dow jones index ↗

September 25, 2026

Via Chartmill

September 25, 2026

Merck’s Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2b/3 BRUNELLO Study of Adults with Diabetic Macular Edema

Stay informed with the top movers within the dow jones index on Thursday. ↗

September 24, 2026

Via Chartmill

Thursday's session: top gainers and losers in the dow jones index ↗

September 24, 2026

Via Chartmill

September 24, 2026

From Merck & Co.

U.S. FDA Approves Update to the Label for WINREVAIR™ (sotatercept-csrk) to Include Data from the Phase 3 HYPERION Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)

Wednesday's session: top gainers and losers in the dow jones index ↗

September 23, 2026

Via Chartmill

Stay informed with the top movers within the dow jones index on Wednesday. ↗

September 23, 2026

Via Chartmill

3 Healthcare Stocks with Warning Signs

September 23, 2026

Via StockStory

Tuesday's session: top gainers and losers in the dow jones index ↗

September 22, 2026

Via Chartmill

Uncover the latest developments among dow jones stocks in today's session. ↗

September 22, 2026

Via Chartmill

September 22, 2026